Logo image of SMMT

SUMMIT THERAPEUTICS INC (SMMT) Stock Analyst Earnings Estimates

NASDAQ:SMMT - Nasdaq - US86627T1088 - Common Stock - Currency: USD

28.485  +0.41 (+1.48%)

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032
Revenue
YoY % growth
SMMT revenue by date.SMMT revenue by date.
860K
-98.49%
1.81M
110.47%
710K
-60.77%
N/A
-100.00%
37.983M116.38M
206.40%
966.72M
730.66%
2.612B
170.19%
4.615B
76.68%
6.822B
47.82%
8.68B
27.24%
EBITDA
YoY % growth
SMMT ebitda by date.SMMT ebitda by date.
-50.78M
-488.82%
-84.84M
-67.07%
-62.36M
26.50%
N/A
-41.98%
-224.001M
-138.21%
-294.746M
-39.76%
-401.426M
-36.19%
-500.696M
-24.73%
N/AN/AN/AN/AN/A
EBIT
YoY % growth
SMMT ebit by date.SMMT ebit by date.
-52.33M
-563.51%
-86.19M
-64.70%
-63.62M
26.19%
N/A
-39.48%
-226.217M
-137.78%
-312.721M
-48.22%
-397.428M
-27.09%
-410.421M
-3.27%
356.21M
186.79%
1.955B
448.83%
3.789B
93.81%
5.46B
44.10%
6.739B
23.42%
Operating Margin
SMMT operating margin by date.SMMT operating margin by date.
-6,084.88%-4,761.88%-8,960.56%N/AN/AN/A-1,046.33%-352.66%36.85%74.85%82.10%80.04%77.64%
EPS
YoY % growth
SMMT eps by date.SMMT eps by date.
-3.39N/AN/AN/A-0.31
-106.67%
-0.41
-31.45%
-0.50
-21.98%
-0.54
-9.46%
0.05
109.41%
1.47
2,761.35%
3.30
125.45%
5.14
55.66%
6.63
28.97%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q2 / 25 Q3 / 25 Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26
EPS
Q2Q % growth
-0.10
-7.10%
-0.11
-31.71%
-0.12
-49.43%
-0.10
-7.67%
-0.13
-32.28%
-0.13
-21.01%
-0.14
-19.45%
Revenue
Q2Q % growth
8.384M13.43M18.802M17.17M
EBITDA
Q2Q % growth
-66.466M
-49.15%
-68.063M
-16.72%
-69.889M
-6.66%
N/AN/AN/AN/A
EBIT
Q2Q % growth
-74.037M
-65.97%
-80.385M
-37.70%
-91.549M
-39.53%
-104.89M
-42.12%
-129.54M
-74.97%
-142.8M
-77.64%
-155.04M
-69.35%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q1 2025
Q2Q % growth
-0.09
-50.00%
-0.090.003.04%
Q4 2024
Q2Q % growth
-0.08
-100.00%
-0.080.003.77%
Q3 2024
Q2Q % growth
-0.08
-166.67%
-0.07-0.01-17.64%
Q2 2024
Q2Q % growth
-0.09
-350.00%
-0.06-0.03-42.31%
Q1 2024
Q2Q % growth
-0.06 -0.060.001.96%
Q4 2023
Q2Q % growth
-0.04
42.86%
%
Q3 2023
Q2Q % growth
-0.03
78.57%
%
Q3 2022
Q2Q % growth
-0.14
86.00%
%
Q3 2021
Q2Q % growth
-1.00
19.35%
-0.30-0.70-238.07%
Q2 2021
Q2Q % growth

99.77%
0.00%
Q1 2021
Q2Q % growth
-1.05
-950.00%
0.00-1.05-39,799.68%
Q4 2020
Q2Q % growth
-0.90 0.00-0.90-40,006.95%
Q3 2020
Q2Q % growth
-1.24 -0.01-1.23-10,852.13%
Q2 2020
Q2Q % growth
-1.15 -0.02-1.13-5,537.25%
Q1 2020
Q2Q % growth
-0.10 -0.02-0.08-390.20%
SMMT Yearly EPS VS EstimatesSMMT Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 2 -2 4 6
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q4 2024
Q2Q % growth

-100.00%
%
Q3 2024
Q2Q % growth

-100.00%
%
Q3 2023
Q2Q % growth
270K
22.73%
%
Q2 2023
Q2Q % growth

-100.00%
%
Q1 2023
Q2Q % growth

-100.00%
%
Q4 2022
Q2Q % growth

-100.00%
%
Q3 2022
Q2Q % growth
220K
-83.21%
%
Q2 2022
Q2Q % growth
240K
300.00%
%
Q1 2022
Q2Q % growth
250K
31.58%
%
Q4 2021
Q2Q % growth
250K
31.58%
%
Q3 2021
Q2Q % growth
1.31M
627.78%
1.31M%
Q2 2021
Q2Q % growth
60K
-64.71%
4.518M-4.458M-98.67%
Q1 2021
Q2Q % growth
190K
-40.63%
4.495M-4.305M-95.77%
Q4 2020
Q2Q % growth
190K 3.913M-3.723M-95.14%
Q3 2020
Q2Q % growth
180K
20.00%
4.041M-3.861M-95.55%
Q2 2020
Q2Q % growth
170K
6.25%
4.59M-4.42M-96.30%
Q1 2020
Q2Q % growth
320K
-34.69%
5.171M-4.851M-93.81%
SMMT Yearly Revenue VS EstimatesSMMT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2026 2027 2028 2029 2030 2031 2032 2B 4B 6B 8B
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0% 0% 0.54% 3.68%
RevenueN/A N/A N/A N/A